IRIS

REGA, MICHELE FORTUNATO

REGA, MICHELE FORTUNATO  

Mostra records
Risultati 1 - 20 di 24 (tempo di esecuzione: 0.024 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
DESIGN, PRODUCTION AND CHARACTERIZATION OF NEW PROTEIN SWEETENERS 8.02 Comunicazioni a Convegni o Seminari 2014 Donnarumma, Federica; Rega, MICHELE FORTUNATO; DI MONACO, Rossella; Cavella, Silvana; Picone, Delia
Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins. 1.1 Articolo in rivista 2009 Wei, J; Kitada, S; Rega, MICHELE FORTUNATO; Emdadi, A; Yuan, H; Cellitti, J; Stebbins, Jl; Zhai, D; Sun, J; Yang, L; Dahl, R; Zhang, Z; Wu, B; Wang, S; Reed, Ta; Wang, Hg; Lawrence, N; Sebti, S; Reed, Jc; Pellecchia, M.
Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cells. 1.1 Articolo in rivista 2009 Rozanov, Dv; Savinov, Ay; Golubkov, Vs; Rozanova, Ol; Postnova, Ti; Sergienko, Ea; Vasile, S; Aleshin, Ae; Rega, MICHELE FORTUNATO; Pellecchia, M; Strongin, Ay
Discovery and binding studies on a series of novel Pin1 ligands. 1.1 Articolo in rivista 2009 Wu, B; Rega, MICHELE FORTUNATO; Wei, J; Yuan, H; Dahl, R; Zhang, Z; Pellecchia, M.
BI-97C1, an Optically Pure Apogossypol Derivative as Pan-Active Inhibitor of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins 1.1 Articolo in rivista 2010 Jun, Wei; John L., Stebbins; Shinichi, Kitada; Rupesh, Dash; William, Placzek; Rega, MICHELE FORTUNATO; Bainan, Wu; Jason, Cellitti; Dayong, Zhai; Li, Yang; Russell, Dahl; Paul B., Fisher; John C., Reed; Maurizio, Pellecchia
Identification of Lead Compounds As Antagonists of Protein Bcl-xLwith a Diversity-Oriented Multidisciplinary Approach 1.1 Articolo in rivista 2009 Simone Di, Micco; Romina, Vitale; Maurizio, Pellecchia; Rega, MICHELE FORTUNATO; Renata, Riva; Andrea, Basso; Giuseppe, Bifulco
Enantioselective aldol condensation of O-silyldienolates derived from alkyl-substituted 2,2-dimethyl-[1,3]-dioxin-4-ones 1.1 Articolo in rivista 2004 Margherita De, Rosa; Maria R., Acocella; Rega, MICHELE FORTUNATO; Arrigo, Scettri
Apogossypol Derivatives as Pan-Active Inhibitors of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins 1.1 Articolo in rivista 2009 Jun, Wei; Shinichi, Kitada; Rega, MICHELE FORTUNATO; John L., Stebbins; Dayong, Zhai; Jason, Cellitti; Hongbin, Yuan; Aras, Emdadi; Russell, Dahl; Ziming, Zhang; Li, Yang; John C., Reed; Maurizio, Pellecchia
Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens. 1.1 Articolo in rivista 2007 Shiryaev, Sa; Remacle, Ag; Ratnikov, Bi; Nelson, Na; Savinov, Ay; Wei, G; Bottini, M; Rega, MICHELE FORTUNATO; Parent, A; Desjardins, R; Fugere, M; Day, R; Sabet, M; Pellecchia, M; Liddington, Rc; Smith, Jw; Mustelin, T; Guiney, Dg; Lebl, M; Strongin, Ay
Robust lanthanide-based assays for the detection of anti-apoptotic Bcl-2-family protein antagonists. 1.1 Articolo in rivista 2007 Rega, MICHELE FORTUNATO; Reed, Jc; Pellecchia, M.
Synthesis and Biological Evaluation of Apogossypolone Derivatives as Pan-active Inhibitors of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins 1.1 Articolo in rivista 2010 Jun, Wei; Shinichi, Kitada; John L., Stebbins; William, Placzek; Dayong, Zhai; Bainan, Wu; Rega, MICHELE FORTUNATO; Ziming, Zhang; Jason, Cellitti; Li, Yang; Russell, Dahl; John C., Reed; Maurizio, Pellecchia
Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists. 1.1 Articolo in rivista 2009 Wei, J; Rega, MICHELE FORTUNATO; Kitada, S; Yuan, H; Zhai, D; Risbood, P; Seltzman, Hh; Twine, Ce; Reed, Jc; Pellecchia, M.
Development of paramagnetic probes for molecular recognition studies in protein kinases. 1.1 Articolo in rivista 2008 Vazquez, J; De, Sk; Chen, Lh; Riel Mehan, M; Emdadi, A; Cellitti, J; Stebbins, Jl; Rega, MICHELE FORTUNATO; Pellecchia, M.
Structure-based discovery of a new class of Bcl-xL antagonists. 1.1 Articolo in rivista 2007 Rega, MICHELE FORTUNATO; Leone, M; Jung, D; Cotton, Nj; Stebbins, Jl; Pellecchia, M.
Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid. 1.1 Articolo in rivista 2006 Becattini, B; Culmsee, C; Leone, M; Zhai, D; Zhang, X; Crowell, Kj; Rega, MICHELE FORTUNATO; Landshamer, S; Reed, Jc; Plesnila, N; Pellecchia, M.
An optically pure apogossypolone derivative as potent pan-active inhibitor of anti-apoptotic bcl-2 family proteins. 1.1 Articolo in rivista 2011 Wei, J; Stebbins, Jl; Kitada, S; Dash, R; Zhai, D; Placzek, Wj; Wu, B; Rega, MICHELE FORTUNATO; Zhang, Z; Barile, E; Yang, L; Dahl, R; Fisher, Pb; Reed, Jc; Pellecchia, M.
SAR by interligand nuclear overhauser effects (ILOEs) based discovery of acylsulfonamide compounds active against Bcl-x(L) and Mcl-1. 1.1 Articolo in rivista 2011 Rega, MICHELE FORTUNATO; Wu, B; Wei, J; Zhang, Z; Cellitti, Jf; Pellecchia, M.
“First investigation of potential adverse effects and environmental impact of new sugar replacers derived from the sweet protein monellin” 4.3 Poster 2015 Rega, MICHELE FORTUNATO; Siciliano, A.; Guida, ; D. Picone, M. Guida; D. P. i. c. o. n., E.
Design of sweet protein based sweeteners: Hints from structure?function relationships 1.1 Articolo in rivista 2015 Rega, MICHELE FORTUNATO; DI MONACO, Rossella; Leone, Serena; Donnarumma, Federica; Roberta, Spadaccini; Cavella, Silvana; Picone, Delia
Influence of pH on the structure and stability of the sweet protein MNEI 1.1 Articolo in rivista 2016 Spadaccini, Roberta; Leone, Serena; Rega, MICHELE FORTUNATO; Richter, Christian; Picone, Delia